It is at the cellular and molecular level, designed for the treatment of well-defined carcinogenic sites, and designing corresponding therapeutic drugs. When drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing tumor cells to die specifically, without Will affect the normal tissue cells around the tumor.
This report contains market size and forecasts of Injectable Targeted Therapy in Global, including the following market information:
Global Injectable Targeted Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Injectable Targeted Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Injectable Targeted Therapy include Novartis, Sanofi, GSK, Bayer, Amgen, Merck, AbbiVie, AstraZeneca and Teva, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Injectable Targeted Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Targeted Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Injectable Targeted Therapy Market Segment Percentages, by Type, 2021 (%)
Monoclonal Antibodies
Small-Molecules
Immunotoxins
Others
Global Injectable Targeted Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Injectable Targeted Therapy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Homecare
Specialty Clinics
Others
Global Injectable Targeted Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Injectable Targeted Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Targeted Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Injectable Targeted Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Sanofi
GSK
Bayer
Amgen
Merck
AbbiVie
AstraZeneca
Teva
Roche
Pfizer